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Plasma membrane receptors can be endocytosed through clathrin-
dependent and clathrin-independent pathways. Here, we show
that the epidermal growth factor (EGF) receptor (EGFR), when
stimulated with low doses of EGF, is internalized almost exclusively
through the clathrin pathway, and it is not ubiquitinated. At higher
concentrations of ligand, however, a substantial fraction of the
receptor is endocytosed through a clathrin-independent, lipid
raft-dependent route, as the receptor becomes ubiquitinated. An
ubiquitination-impaired EGFR mutant was internalized through
the clathrin pathway, whereas an EGFRubiquitin chimera, that
can signal solely through its ubiquitin (Ub) moiety, was internal-
ized exclusively by the non-clathrin pathway. Non-clathrin inter-
nalization of ubiquitinated EGFR depends on its interaction with
proteins harboring the Ub-interacting motif, as shown through the
ablation of three Ub-interacting motif-containing proteins, eps15,
eps15R, and epsin. Thus, eps15s and epsin perform an important
function in coupling ubiquitinated cargo to clathrin-independent
internalization.
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Ubiquitination is a posttranslational modification wherebysubstrate proteins are conjugated to a short highly con-
served peptide, ubiquitin (Ub), through the action of Ub ligases
(E3 enzymes). Polyubiquitination, in which a chain of Ub is
appended, targets proteins to proteasomal degradation (1).
However, when a single Ub moiety is appended (monoubiquiti-
nation), the modification functions as a signaling device through
interactions with intracellular proteins harboring Ub-binding
domains, such as the Ub-interacting motif (UIM) (2). In yeast,
monoubiquitination has been known to act as an internalization
signal for quite some time (3). In mammals, however, this
connection has remained more elusive.
We are interested in the mechanisms of internalization of
receptor tyrosine kinases and, in particular, the epidermal
growth factor receptor (EGFR). The EGFR is monoubiquiti-
nated at multiple sites (4) through the action of the E3 enzyme
Cbl. Although there is consensus on the function of Cbl and
receptor ubiquitination in intracellular sorting of the EGFR,
their role in the internalization step of endocytosis is less clear
(5, 6). To gain insight into this issue, we generated a chimera in
which the extracellular and transmembrane domains of the
EGFR are fused to a mutant Ub (Ubmut), unable to form
polyUb chains (EGFRUbmut). With this chimera, we showed
that ubiquitination is sufficient for internalization (4). The
present studies were undertaken to elucidate the molecular
mechanisms through which receptor ubiquitination directs
internalization.
Materials and Methods
Transfection and Biochemical Studies. Transfections were per-
formed by using Lipofectamine or Oligofectamine (Invitrogen).
For biochemical experiments, cells were serum-starved and then
stimulated with EGF (100 ngml, unless otherwise indicated) at
37°C. Lysis, immunoprecipitation, and immunoblotting were
performed as described in ref. 7. Plasmids, pharmacological
agents, and antibodies are described in Supporting Materials and
Methods, which is published as supporting information on the
PNAS web site.
Gene Silencing. Gene silencing of eps15, eps15R, or epsin was
obtained by pSUPER vectors encoding specific targeting se-
quences. Two distinct small interfering RNAstargets were
tested, with comparable results. Stable clones were obtained by
cotransfection with a plasmid carrying puromycin resistance.
Three independent clones were analyzed with similar results.
Silencing of clathrin heavy chain was by transient transfection of
two different short interfering RNA oligos (which yielded com-
parable results) directed against the two previously described
sequences (8, 9). Further details are in Supporting Materials and
Methods.
Immunofluorescence and Internalization Studies. Immunofluores-
cence, internalization of rhodaminated ligands, 125I-EGF or
13A9 antibody were performed as described in ref. 4. At the
single cell level, endocytosis was monitored both by rhodamine-
EGF and by anti-EGFR 13A9 antibody (which does not interfere
with EGFR internalization) with comparable results (only one of
the two procedures is shown in the pictures). Rhodaminated
EGF (1 gml) or the 13A9 antibody (20 gml in the presence
of EGF) were added for 1 h at 0°C, followed by wash and shift
at 37°C for 20–30 min to allow internalization. After fixation,
13A9 was detected with Cy3-conjugated secondary antibody. In
assays with anti-hemagglutinin (anti-HA) (see Fig. 6B), 20
gml anti-HA was substituted for 13A9. Quantitation was
performed on at least two experiments, in duplicate (100 cells
per condition). Plasma membrane staining was compared with
intracellular vesicle-associated staining. Internalizing cells dis-
played preponderant intracellular staining but little, if any,
plasma membrane staining. Noninternalizing cells displayed the
opposite phenotype.
Immunoelectron Microscopy. For preembedding immunolabeling
(Figs. 1A and 2B Left and Center and Table 1), starved prechilled
cells were incubated on ice for 30 min with 20 gml anti-EGFR
13A9, then with rabbit anti-mouse (code no. ZO412, DAKO),
and finally with 10-nm protein A-gold. Cells were then incubated
at 37°C for 2 min with EGF (at the indicated doses), fixed for 15
min at room temperature (2.5% glutaraldehyde in 0.1 M caco-
dylate buffer, pH 7.2), and processed as described in ref. 10.
Abbreviations: KD, knockdown; Ub, ubiquitin; UBmut, mutant Ub; UIM, Ub-interacting
motif; HA, hemagglutinin.
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ImmunoGold labeling on ultrathin cryosections (Figs. 2B Right
and 4B) was performed as reported in ref. 10. Further details are
in Supporting Materials and Methods.
Results
In HeLa cells, expressing endogenous EGFR, we found that
EGFR follows different internalization routes, depending on the
dose of EGF.We used two concentrations of EGF (low EGF, 1.5
ngml; high EGF, 20 ngml), both within the range of physio-
logical EGF levels (1–2 ngml in serum; 10–100 ngml in several
other biological f luids, see Supporting Materials andMethods). At
low EGF, EGFR localized predominantly into clathrin-coated
pits, whereas, at high EGF, the receptor was roughly equally
partitioned between coated pits and caveolae (Fig. 1A and Table
1). At low EGF, the receptor was significantly tyrosine phos-
phorylated and fully competent for downstream signaling (as
demonstrated by activation of ERK), whereas significant ubiq-
uitination was only detectable at high EGF (Fig. 1B). Thus, there
is correlation between the state of EGFR ubiquitination and its
partition into caveolae.
We have shown that a chimera encompassing the extracellular
and transmembrane domain of the EGFR fused to Ub (EGFR
Ubmut) is constitutively internalized (4). By exploiting this
chimera, whose internalization exclusively depends on the sig-
naling abilities of the Ub moiety, we endeavored to determine
how ubiquitination directs internalization. In EGFR-negative
NR6 (Fig. 2A) or Chinese hamster ovary (CHO) (data not
shown) cells, the internalized EGFRUbmut colocalized exten-
sively with caveolin-1, a marker of the non-clathrin lipid raft
caveolar pathway, but poorly with clathrin, whereas a transfected
EGFR (EGFRwt) showed the opposite behavior (Fig. 2A). By
immunoelectron microscopy, we detected EGFRUbmut exclu-
sively in caveolae (Fig. 2B), whereas EGFRwt partitioned be-
tween coated pits and caveolae, with preference for coated pits
(data not shown). Consistently, by lipid raft fractionization
Fig. 1. Internalization of EGFR at different doses of EGF. (A) Immunoelectron
microscopy of EGFRwt in HeLa cells in coated pits (CP), coated vesicles (CV),
caveolae (CAV), or caveosome-like structures (CVS). (Bar, 111 nm.) (B) Lysates
(1 mg) from HeLa cells were immunoprecipitated (IP) or directly loaded (50g)
and immunoblotted (IB) with the indicated antibodies.
Fig. 2. Internalization of EGFRUbmut. (A) NR6 cells expressing EGFRwt or
EGFRUbmut were treated (15 min) with rhodamine-EGF (red) and stained for
either clathrin or caveolin (green). (Left) Boxes enclose areas magnified in
Right (magnification, 4). Similar results were obtained when the internal-
ization assay was performed with the 13A9 anti-EGFR antibodies in the
presence or absence of EGF (data not shown). (B) Immunoelectron microscopy
on NR6 expressing EGFRUbmut or EGFRFLAG [a Ub-less control chimera (4)].
EGFRUbmut is exclusively detected in caveolae (20 cell profiles analyzed).
(Bar, 83 nm.)
Table 1. Morphometry from 10 cell profiles
Organelles EGF at 1.5 ngml, % (n) EGF at 20 ngml, % (n)
Labeled caveolae 4 (72) 22 (106)
Labeled coated pits 40 (35) 30 (46)
Gold in caveolae 1 (296) 12 (383)
Gold in coated pits 16 (296) 15 (383)
Shown is the percentage of labeled organelles, with values in parentheses
representing the number of caveolae or coated pits counted, or the percent-
age of gold particles in organelles, with the values in parentheses represent-
ing the total gold particles detected on the plasma membrane.
















experiments, the EGFRUbmut partitioned 10-fold more than
the EGFRwt in the raft fractions (Fig. 7, which is published as
supporting information on the PNAS web site).
Next, we used pharmacological and dominant negative inhib-
itors of endocytosis and comparatively tested their effects on
EGFRwt, EGFRUbmut, and a mutant EGFR (Y1045F), that
cannot efficiently recruit Cbl (11), thus showing considerably
reduced ubiquitination (Fig. 3A). All these constructs were
expressed in EGFR-negative CHO or NR6 cells.
In an initial set of experiments, we monitored internalization
of rhodamine-conjugated EGF (Fig. 3 B and C; see Fig. 8, which
is published as supporting information on the PNAS web site).
DynaminII-K44A, a general endocytic inhibitor (12, 13), abro-
gated internalization of EGFRUbmut, EGFRwt, and Y1045F
(Fig. 3B). Conversely, a mutant eps15 (95295), which inter-
feres predominantly with AP2 (14), or an amphiphysin fragment
(A1SRR) that selectively interferes with clathrin (15) was
ineffective on endocytosis of EGFRUbmut, while reducing
internalization of EGFRwt and Y1045F (Fig. 3B). Pharmaco-
logical tools (filipin, nystatin, and low-dose genistein) that allow
preferential interference with non-clathrin internalization (16,
17) effectively inhibited the internalization of EGFRUbmut
(Fig. 3C). Of note, a different chimeric receptor harboring the
extracellular domain of the transferrin receptor and intracellular
Ub, was also internalized through a nystatin and filipin-sensitive
pathway, whereas the wild-type transferrin receptor, which is
internalized exclusively through coated pits, was insensitive to
these drugs (Fig. 9, which is published as supporting information
on the PNAS web site). EGFRwt was inhibited by the drugs to
a lesser, albeit significant, extent (Fig. 3C). Conversely, the
internalization of the Y1045F mutant was insensitive to these
inhibitors (Fig. 3C).
A quantitative assessment was obtained by measuring the
internalization of 125I-EGF (Fig. 3D). At high EGF, although
the internalization of EGFRwt was partially sensitive to filipin,
the drug had no significant effect on endocytosis of the Y1045
mutant, but it reduced the internalization of EGFRUbmut to
background levels (Fig. 3D).
How does Ub couple with the intracellular machinery of
non-clathrin endocytosis? A family of UIM-containing proteins
has been implicated in endocytosis, with eps15 and epsin func-
tioning at the plasma membrane (10, 18, 19) and hepatocyte
growth factor receptor substrate (HRS) in endosomes (20).
These proteins coimmunoprecipitated with EGFRUbmut (Fig.
4A) and were also found in caveolae containing the chimera and
caveolin-1 (Fig. 4B). In addition, the overexpression of an
isolated UIM inhibited the internalization of EGFRUbmut but
not of the transferrin receptor (Fig. 4C). Finally, when EGFR
Ubmut was modified, such as to harbor a Ub moiety incapable
of interacting with UIMs (21), it could not be internalized any
longer (Fig. 10, which is published as supporting information on
the PNAS web site). UIM proteins also coimmunoprecipitated
with endogenous EGFR in a ligand-dependent fashion and with
a time kinetic compatible with function(s) at different stations of
the endocytic route (Fig. 5A). Of interest, eps15 showed a second
peak of association at late time points, suggesting an additional
role(s) at the endosomal level, as also recently suggested (22).
The association depended on the presence of Ub and functional
UIMs, as shown by the lack of coimmunoprecipitation of
Y1045F with the three UIM proteins (Fig. 5B) and the lack of
endogenous EGFR with mutant eps15 and epsin, which were
carrying deletions in their UIMs (Fig. 5C). Thus, Ub, either
biosynthetically added to EGFRUbmut or posttranslationally
appended to EGFR, might direct the receptors to non-clathrin
internalization through an interaction(s) with UIM proteins.
To address this point, we knocked down (KD) eps15, eps15R
(a related protein), and epsin in HeLa cells (Fig. 6A). The
endocytosis of EGFRUbmut was abrogated in triple eps15
eps15Repsin KD cells but not in individual KD cells (Fig. 6B;
see Fig. 11A, which is published as supporting information on the
PNAS web site). The reexpression of eps15 but not of an
eps15-UIM-deleted mutant in the triple KD cells restored the
internalization of EGFRUbmut (Fig. 6B, see Fig. 11B). Thus,
Fig. 3. Ubiquitination and internalization. (A) Lysates (5 mg) from CHO cells expressing EGFRwt or Y1045F were immunoprecipitated (IP) and immunoblotted
(IB) with the indicated antibodies. (B) CHO cells were cotransfected with the indicated GFP-tagged and various EGFR-based constructs and incubated with
rhodamine-EGF. The bar graphs represent the percentage of cells in which EGF internalization was inhibited (normalized to control GFP-transfected cells). (C)
NR6 cells expressing the indicated constructs were treated with the indicated drugs. Internalization was monitored with the anti-EGFR 13A9 antibody in the
presence of high EGF. (D) NR6 cells expressing the indicated constructs were treated with filipin and then incubated with 20 ngml 125I-EGF for 15 min at 37°C.
The rate of internalization is expressed as internalizedsurface-bound radioactivity. Actual images of the experiments described for B and C are in Fig. 8.
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when a membrane protein is exclusively internalized as a func-
tion of its ubiquitination in a nystatinfilipin-sensitive pathway,
the interaction with the UIM proteins eps15eps15Repsin is
essential. In addition, the functions of eps15eps15R and epsin
are redundant in this pathway.
We then investigated the behavior of the endogenous EGFR.
Initially, we investigated the role of clathrin because discordant
results have been reported (8, 9, 23).We reasoned that the scarce
effect of clathrin KD in one of these studies could be explained
by the use of high EGF in the internalization assay (8). Accord-
ing to our present data, under those conditions the contribution
of a clathrin-independent pathway (defined on the basis of its
Fig. 4. UIM proteins and EGFRUbmut. (A) -NX cells were transfected as
indicated above the gels. Lysates (5 mg) were immunoprecipitated (IP) and
immunoblotted (IB) as indicated. (B) Immunoelectron microscopy of NR6 express-
ing EGFRUbmut. (Bar, 83 nm.) Arrowheads point to caveolar membranes. Note
that in cells expressing the EGFRFLAG control chimera, eps15 and epsin were
never detected in caveolae (data not shown). (C) CHO cells were cotransfected
withEGFRUbmutandeitherGFPorGFP-UIM(aminoacids842–897ofeps15)and
incubatedwithrhodamine-EGF(red,Left)or rhodamine-transferrin (red,Center).
Merged images are shown. (Right) A quantitative assessment of EGF internaliza-
tion (3 ngml 125I-EGF for 15 min at 37°C).
Fig. 5. UIM proteins bind to ubiquitinated EGFR. (A) Lysates (5 mg) from HeLa
cells were immunoprecipitated (IP) and immunoblotted (IB) with the indicated
antibodies. (B) CHO cells were transiently cotransfected with either EGFRwt or
Y1045F and individually transfected with epsin, eps15, and hepatocyte growth
factor receptor substrate (Hrs). Lysates (2 mg) were immunoprecipitated
immunoblotted as indicated. (C) HeLa cells were transfected with the indicated
FLAG-tagged constructs encoding wild-type eps15 or an eps15-UIM-deleted mu-
tant [eps15859–897 (29)], or wild-type epsin, or an epsin-UIM-deleted mutant
[epsin190–192 (29)]. FLAG is an empty control vector. Lysates (2 mg) were
immunoprecipitatedimmunoblotted as indicated.
















nystatinfilipin sensitivity) would be substantial. As shown in
Fig. 6C, at low EGF, the KD of clathrin (levels of clathrin in KD
cells are in Fig. 6A) almost completely abrogated internalization,
demonstrating that, under this condition, clathrin is absolutely
required. Next, we tested whether UIM-containing proteins are
required in this pathway. At low EGF, although the individual
KDs of eps15eps15R or epsin had no effect, the triple eps15
eps15Repsin KD exhibited a significant decrease in EGFR
internalization (Fig. 6C). Treatment with filipin had no effect in
any of the KDs at low EGF (Fig. 6D). These results are in
agreement with those reported by Huang et al. (23) and dem-
onstrate that eps15eps15R and epsin participate (redundantly)
also in the clathrin pathway. However, they are not strictly
essential, as clathrin endocytosis proceeds also in their absence.
At high EGF, clathrin KD reduced internalization by 50%.
However, filipin treatment of clathrin KD cells reduced the
residual internalization to background levels (Fig. 6D). These
results show the existence of two modalities of internalization,
one relying on clathrin (at low EGF) and one relying both on
clathrin-dependent and clathrin-independent pathways (at high
EGF). The triple eps15eps15Repsin KD also reduced EGFR
endocytosis at high EGF, albeit in a filipin-insensitive fashion,
demonstrating that, in the triple KD, the non-clathrin nystatin
filipin-sensitive component of EGFR endocytosis is completely
abolished (Fig. 6D). Individual KDs of eps15eps15R or epsin
had no effect, reinforcing the notion of redundancy among these
proteins (data not shown). Finally, the quadruple eps15
eps15Repsinclathrin KD reduced EGFR internalization at
high and low doses to background levels (Fig. 6 C and D).
Together with data obtained with EGFRUbmut, these results
prove that eps15eps15R and epsin are (redundantly) indispens-
able to the non-clathrin internalization of the EGFR.
Discussion
Our studies unveil important differences in the mechanisms
through which the EGFR couples with the machinery of inter-
nalization as a function of EGF dose. At low doses of ligand, the
receptor is almost exclusively internalized through a clathrin-
dependent mechanism, whereas, at higher doses, a non-clathrin
pathway defined on the basis of its nystatinfilipin-sensitivity
emerges and becomes as relevant as the clathrin pathway. Of
note, low and high EGF concentrations are physiologically
relevant, as discussed in Supporting Materials and Methods. The
emergence of the non-clathrin pathway correlates with the
appearance of detectable ubiquitinated EGFR. A molecular
genetics approach provided a mechanistic basis for this corre-
lation, because a mutant EGFR that can no longer be ubiqui-
tinated (Y1045F) was internalized through the clathrin pathway,
even at high doses of EGF.
The dependence of the non-clathrin pathway on ubiquitina-
tion was further confirmed by a reductionistic approach, which
exploited chimeric molecules that can signal solely through an
Ub moiety. It should also be pointed out that such molecules are
not ‘‘true’’ representations of receptors. In the case of the
EGFR-based chimera, we have previously demonstrated that the
chimera is constitutively internalized and routed to the degra-
dative compartment, even in the absence of ligand stimulation
(4). Once, however, the relevance of ubiquitination in non-
clathrin endocytosis was established on the holo-EGFR, as
discussed above, the chimera proved very useful in simplifying
the plethora of signals present on an activated receptor and in
allowing studies of internalization solely as a function of cargo
ubiquitination.
Our results are consistent with data showing that EGFR
internalization through clathrin-coated pits requires Cbl but not
receptor ubiquitination (5, 24). These latter findings also indi-
rectly stress the importance of Cbl-executed ubiquitination of
other downstream endocytic proteins for proper clathrin endo-
cytosis. A recent report by Stang et al. (25), which shows that
Cbl-dependent ubiquitination is required for progression of the
EGFR into coated pits, further reinforces this notion. Taken
Fig. 6. Effects of multiple KDs on internalization. (A) (Top) Lysates from HeLa
KD stable clones () for eps15eps15R, epsin, or eps15eps15Repsin (triple
KD) or from control clones obtained with mismatched oligos () were immu-
noblotted as indicated. (Middle) EGFR levels were comparable in all clones.
(Bottom) The clathrin levels in the clathrin KDs. (B) (Upper) The indicated HeLa
KD clones were transfected with a HA-EGFRUbmut chimera (see Supporting
Materials and Methods) to circumvent the presence of endogenous EGFR.
Internalization was assessed with an anti-HA antibody. Data are expressed as
the percentage of cells in which internalization was inhibited. (Lower) A HeLa
triple KD clone expressing HA-EGFRUbmut was transfected with the indi-
cated eps15mut constructs (see SupportingMaterials andMethods). Internal-
ization assays and bar graph are as in Upper. Actual images of these experi-
ments are in Fig. 11. (C) HeLa clones harboring the indicated KDs were
incubated with 1.5 ngml 125I-EGF. The rate of internalization is expressed as
internalizedsurface-bound radioactivity. *, P  0.0164; **, P  0.003; linear
regression analysis. (D) The indicated HeLa KD clones were treated with filipin
() or mock treated (), followed by incubation with 1.5 or 20 ngml 125I-EGF
for 6 min at 37°C. The rate of internalization is expressed as internalized
surface-bound radioactivity.
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together with these results, our findings suggest a mechanism
through which ubiquitination of endocytic machinery, but not
cargo ubiquitination, is required for internalization into coated
pits. At higher doses of EGF, however, when cargo ubiquitina-
tion becomes substantial, endocytosis is partially switched to a
non-clathrin pathway.
How is this ‘‘switch’’ achieved? Our results directly implicate
the recruitment of eps15eps15R and epsin to the ubiquitinated
cargo, as also shown by findings that expression of the EGFRUb
chimera was able to induce relocalization of these proteins into
caveolae. In addition, we showed that these proteins are redun-
dantly essential in non-clathrin endocytosis of the EGFR. How
the signal is further propagated downstream of these molecules
in this pathway is not known and warrants further investigation.
Furthermore, other Ub-binding proteins have been implicated in
endocytosis. Thus, their potential role in the internalization of
ubiquitinated cargo, possibly in a cell-specific fashion, also
appears worth investigating.
Our results also indicate a role (albeit nonessential) for
eps15eps15R and epsin in clathrin internalization. Indeed,
these proteins have been implicated in the formation of coated
pits, and they have been proposed to function as adaptors
between ubiquitinated cargo and components of the coat, such
as AP2 and clathrin (2, 26). This latter possibility seems unlikely
based on our present data, at least under a condition in which the
clathrin route is paramount at low EGF concentrations, simply
because there is not sufficient cargo ubiquitination at these
doses. However, we have previously shown that clathrin-
dependent synaptic vesicle recycling in Caenorhabditis elegans is
negatively affected by the removal of eps15 through amechanism
that involves a genetic interaction with dynamin (27). It is
possible, therefore, that, at least in the case of eps15, participa-
tion to clathrin endocytosis involves mechanisms different from
interactions with ubiquitinated cargo.
Finally, we note that the TGF- receptor internalizes through
coated pits and caveolae (28). The two pathways were associated
with increased receptor signaling and rapid receptor degrada-
tion, respectively (28). In the case of EGFR, at low EGF (when
internalization proceeds exclusively through coated pits), the
receptor is already fully competent for effector signaling (Fig.
1B). Conversely, at high EGF (when non-clathrin endocytosis
becomes significant), there is no increase in signaling abilities but
readily detectable increase in EGFR down-regulation (Fig. 1B).
Thus, at minimum, caveolarraft internalization does not ap-
parently contribute to EGFR signaling, and possibly it is pref-
erentially associated with receptor degradation.
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